Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinson's Disease
BMC Neurology - United Kingdom
doi 10.1186/1471-2377-11-112
Full Text
Open PDFAbstract
Available in full text
Date
September 22, 2011
Authors
Publisher
Springer Science and Business Media LLC